14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Feb 18, 2020 $5.64 $5.80 $5.58 $5.60 288 110
Feb 14, 2020 $5.71 $5.79 $5.48 $5.61 321 493
Feb 13, 2020 $5.92 $6.02 $5.70 $5.75 159 506
Feb 12, 2020 $5.67 $6.00 $5.60 $5.96 378 190
Feb 11, 2020 $5.59 $5.70 $5.51 $5.61 152 240
Feb 10, 2020 $5.46 $5.62 $5.46 $5.54 113 526
Feb 07, 2020 $5.54 $5.60 $5.42 $5.47 141 603
Feb 06, 2020 $5.71 $5.72 $5.48 $5.55 137 624
Feb 05, 2020 $5.57 $5.87 $5.48 $5.67 350 846
Feb 04, 2020 $5.39 $5.62 $5.25 $5.51 228 906
Feb 03, 2020 $5.24 $5.40 $5.13 $5.33 270 396
Jan 31, 2020 $5.10 $5.24 $4.95 $5.14 206 165
Jan 30, 2020 $5.25 $5.36 $5.06 $5.10 203 169
Jan 29, 2020 $5.32 $5.43 $5.25 $5.28 202 642
Jan 28, 2020 $5.33 $5.46 $5.19 $5.30 215 165
Jan 27, 2020 $5.13 $5.52 $5.05 $5.27 266 222
Jan 24, 2020 $6.01 $6.02 $5.38 $5.45 278 139
Jan 23, 2020 $5.85 $6.06 $5.70 $6.01 394 402
Jan 22, 2020 $6.02 $6.03 $5.75 $5.88 319 467
Jan 21, 2020 $5.88 $6.13 $5.75 $5.97 358 766
Jan 17, 2020 $5.94 $6.06 $5.80 $5.88 450 849
Jan 16, 2020 $5.74 $5.92 $5.64 $5.90 340 593
Jan 15, 2020 $5.43 $5.77 $5.43 $5.70 398 319
Jan 14, 2020 $5.49 $5.59 $5.23 $5.45 539 450
Jan 13, 2020 $5.19 $5.56 $5.01 $5.50 806 685
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT